ATE529133T1 - Topisches präparat - Google Patents

Topisches präparat

Info

Publication number
ATE529133T1
ATE529133T1 AT05768591T AT05768591T ATE529133T1 AT E529133 T1 ATE529133 T1 AT E529133T1 AT 05768591 T AT05768591 T AT 05768591T AT 05768591 T AT05768591 T AT 05768591T AT E529133 T1 ATE529133 T1 AT E529133T1
Authority
AT
Austria
Prior art keywords
present
mast cell
cell degranulation
degranulation inhibitor
preparation containing
Prior art date
Application number
AT05768591T
Other languages
English (en)
Inventor
Mitsuru Endo
Keiko Yamasaki
Hidetoshi Hamamoto
Sueko Matsumura
Masaki Ishibashi
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Application granted granted Critical
Publication of ATE529133T1 publication Critical patent/ATE529133T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05768591T 2004-08-18 2005-08-01 Topisches präparat ATE529133T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004238167 2004-08-18
JP2005021549 2005-01-28
PCT/JP2005/014468 WO2006018997A1 (ja) 2004-08-18 2005-08-01 外用剤

Publications (1)

Publication Number Publication Date
ATE529133T1 true ATE529133T1 (de) 2011-11-15

Family

ID=35907387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05768591T ATE529133T1 (de) 2004-08-18 2005-08-01 Topisches präparat

Country Status (5)

Country Link
US (1) US7592371B2 (de)
EP (1) EP1782831B1 (de)
JP (1) JP4843824B2 (de)
AT (1) ATE529133T1 (de)
WO (1) WO2006018997A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007046544A1 (ja) * 2005-10-21 2007-04-26 Medrx Co., Ltd. カルボキシル基を有する肥満細胞脱顆粒抑制剤と有機アミンとの塩を含有する外用剤
JP2008031079A (ja) * 2006-07-28 2008-02-14 Sigma Soyaku Kk 花粉症に伴う症状を抑えるための薬剤
EP2128123A4 (de) * 2007-01-29 2011-04-20 Medrx Co Ltd Salz eines nichtsteroidalen antiinflammatorischen arzneimittels und organische aminverbindung und verwendung davon
JP5670008B2 (ja) * 2007-01-31 2015-02-18 大正製薬株式会社 アダパレン含有外用剤組成物
EP2311498A4 (de) * 2008-08-05 2013-07-24 Medrx Co Ltd Externes präparat mit einem fettsäuresalz oder einem benzoesäuresalz aus einer basischen pharmakologischen wirkstoffkomponente sowie verfahren zu seiner herstellung
IN2014DN09031A (de) * 2012-03-30 2015-05-22 Nuformix Ltd
JP6514718B2 (ja) * 2014-05-15 2019-05-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヒト女性生殖器の外陰部領域を襲う痛みを局所的に治療するためのデバイスおよび製剤
KR102597910B1 (ko) 2015-03-26 2023-11-02 재클린 엠. 이베르센 숙취상태와 연관된 증상들을 억제하기 위한 방법 및 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
JPH06128153A (ja) * 1992-10-16 1994-05-10 Kissei Pharmaceut Co Ltd トラニラスト軟膏組成物およびその製造方法
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
ATE222759T1 (de) 1996-02-07 2002-09-15 Lead Chem Co Ltd Tranilast enthaltendes externum und verfahren zu dessen herstellung
HUP9904109A3 (en) * 1996-10-14 2000-11-28 Kowa Co Ltd Nagoya Shi Local anesthetic for external use
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US20010004644A1 (en) 1997-07-21 2001-06-21 Levin Bruce H. Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
ATE269702T1 (de) * 1997-07-21 2004-07-15 Bruce H Levin Zusammensetzungen, kits und verfahren zur hemmung von zerebralen neurovasculären störungen und muskulärem kopfschmerzen
JP4295841B2 (ja) 1998-05-11 2009-07-15 アピ株式会社 抗アレルギー外用剤
JP4684404B2 (ja) 2000-10-26 2011-05-18 第一三共株式会社 消炎鎮痛外用剤組成物
US6468557B1 (en) * 2001-01-05 2002-10-22 Alphamed Pharmaceutical Corp. Method for treating infectious viral diseases
JP4106232B2 (ja) * 2001-05-09 2008-06-25 ロート製薬株式会社 医薬組成物
JP4176358B2 (ja) 2002-03-01 2008-11-05 天藤製薬株式会社 痔疾用医薬組成物
AU2003256284A1 (en) * 2002-06-20 2004-01-06 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
CN103143022A (zh) * 2002-07-30 2013-06-12 奥默罗斯公司 眼科冲洗液及方法
US7166641B2 (en) 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
JP2004161625A (ja) * 2002-11-11 2004-06-10 Noevir Co Ltd 水性スティック状皮膚疾患治療用外用剤

Also Published As

Publication number Publication date
EP1782831B1 (de) 2011-10-19
WO2006018997A1 (ja) 2006-02-23
JP4843824B2 (ja) 2011-12-21
US20080108700A1 (en) 2008-05-08
JPWO2006018997A1 (ja) 2008-05-08
EP1782831A1 (de) 2007-05-09
EP1782831A4 (de) 2009-12-02
US7592371B2 (en) 2009-09-22

Similar Documents

Publication Publication Date Title
CO5590929A2 (es) Derivados de acetileno que tienen actividad antagonica de mgiur5
NO20080068L (no) Topisk unguale formuleringer
DK1631295T3 (da) Anvendelse af kondenserede heterocykliske forbindelser som SCCE-inhibitorer ved behandling af hudsygdomme
CY1109994T1 (el) Βελτιωμενο σχεδιο συνθεσης για τη λακοσαμιδη
UY27729A1 (es) Inhibidores de quinasas.
DE602005026508D1 (de) Monozyklische heterozyklen als kinase-hemmer
TW200610805A (en) Organic electroluminescent devices
TW200639140A (en) Compounds for organic electronic devices
BRPI0511621A (pt) compostos orgánicos
BRPI0514155A (pt) ferramenta para regular alcance magnético integrada
CR9495A (es) Composicion en emulsion estable
AR029696A1 (es) Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra
NO20053663D0 (no) Transdermal granistetron
CY1112406T1 (el) Διενυδρη υδροχλωρικη (s)-(-)-1-(4-φθοροϊσοκινολιν-5-υλ)σουλφονυλ-2-μεθυλ-1,4-ομοπιπεραζινη
ATE404536T1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
CR7717A (es) Nuevos inhibidores biciclicos de hormona sensitiva a la lipasa
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
EA200700537A1 (ru) Триазолофталазины
EP1782831A4 (de) Topisches präparat
DK1973539T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression
EP1667685A4 (de) Chinazolin-kaliumkanalhemmer
CR9472A (es) Derivados de aminoacidos
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
CO5700779A2 (es) Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas
EA200700360A1 (ru) Новые производные амида гетероциклической карбоновой кислоты

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties